Egg-derived and formulation proteins

Egg-derived and formulation proteins refers to a heterogeneous group of proteins that are either residual impurities from the manufacturing process or intentional additives used to stabilize pharmaceutical products. Egg-derived proteins, most notably ovalbumin, ovomucoid, and ovotransferrin, are frequently found in vaccines produced in embryonated chicken eggs, such as those for influenza and yellow fever [1][2]. Formulation proteins include excipients like human serum albumin (HSA) or gelatin, which are added to biologics to prevent aggregation and maintain the structural integrity of the active ingredient [3][5]. While these proteins do not serve as therapeutic targets for drug action, they are clinically significant as potential allergens that can induce IgE-mediated hypersensitivity or anaphylaxis in susceptible patients [4]. Monitoring the concentration of these proteins is a critical quality control step in biopharmaceutical manufacturing to ensure patient safety [5]. Consequently, they represent a challenge in formulation science and clinical immunology rather than a site for therapeutic intervention.

Other names

Egg allergensVaccine excipientsResidual egg proteinsFormulation stabilizersOvalbuminOvomucoidOvotransferrinLysozymeHuman serum albuminGelatin

These proteins do not serve as therapeutic targets; instead, they act as allergens that can trigger IgE-mediated mast cell degranulation in sensitized individuals or serve as stabilizing agents to maintain the structural integrity and potency of biopharmaceutical formulations [1][4].